CONICET-Universidad Austral, Instituto de Investigaciones en Medicina Traslacional (IIMT), Developmental Biology & Regenerative Medicine Laboratory, Argentina.
CONICET-Universidad Austral, Instituto de Investigaciones en Medicina Traslacional (IIMT), Developmental Biology & Regenerative Medicine Laboratory, Argentina.
Dev Biol. 2021 Sep;477:117-132. doi: 10.1016/j.ydbio.2021.05.010. Epub 2021 May 26.
During embryonic stages, vascular endothelial cells (ECs) originate from the mesoderm, at specific extraembryonic and embryonic regions, through a process called vasculogenesis. In the adult, EC renewal/replacement mostly depend on local resident ECs or endothelial progenitor cells (EPCs). Nevertheless, contribution from circulating ECs/EPCs was also reported. In addition, cells lacking from EC/EPC markers with in vitro extended plasticity were shown to originate endothelial-like cells (ELCs). Most of these cells consist of mesenchymal stromal progenitors, which would eventually get mobilized from the bone marrow after injury. Based on that, current knowledge on different mouse and human bone marrow stromal cell (BM-SC) subpopulations, able to contribute with mesenchymal stromal/stem cells (MSCs), is herein reviewed. Such analyses underline an unexpected heterogeneity among sinusoidal LepR stromal/CAR cells. For instance, in a recent report a subgroup of LepR stromal/CAR progenitors, which express GLAST and is traced in Wnt1;R26R mice, was found to contribute with ELCs in vivo. These GLAST Wnt1 BM-SCs were shown to get mobilized to the peripheral blood and to contribute with liver regeneration. Other sources of ELCs, such as adipose, neural and dental pulp tissues, were also published. Finally, mechanisms likely involved in the enhanced cellular plasticity properties of bone marrow/adipose tissue stromal cells, able to originate ELCs, are assessed. In the future, strategies to analyze the in vivo expression profile of stromal cells, with MSC properties, in combination with screening of active genomic regions at the single cell-level, during early postnatal development and/or after injury, will likely help understanding properties of these ELC sources.
在胚胎期,血管内皮细胞(ECs)来源于中胚层,在特定的胚外和胚胎区域,通过血管发生过程。在成人中,EC 的更新/替代主要依赖于局部常驻 EC 或内皮祖细胞(EPCs)。然而,也有报道称循环 EC/EPC 有贡献。此外,还显示具有体外扩展可塑性的缺乏 EC/EPC 标记的细胞起源于内皮样细胞(ELCs)。这些细胞中的大多数由间充质基质祖细胞组成,这些细胞最终会在受伤后从骨髓中动员出来。基于此,本文综述了不同的小鼠和人类骨髓基质细胞(BM-SC)亚群,能够作为间充质基质/干细胞(MSCs)贡献的当前知识。这些分析强调了窦状隙 LepR 基质/CAR 细胞之间存在出乎意料的异质性。例如,在最近的一份报告中,发现表达 GLAST 并在 Wnt1;R26R 小鼠中追踪的 LepR 基质/CAR 祖细胞的一个亚群,能够在体内产生 ELCs。这些 GLAST Wnt1 BM-SCs 被证明可以动员到外周血中,并有助于肝脏再生。还发表了其他 ELC 来源,如脂肪、神经和牙髓组织。最后,评估了可能涉及增强具有 MSC 特性的骨髓/脂肪组织基质细胞产生 ELCs 的细胞可塑性特性的机制。将来,分析具有 MSC 特性的基质细胞在体内的表达谱的策略,结合在早期出生后发育和/或受伤后对单个细胞水平的活性基因组区域进行筛选,可能有助于了解这些 ELC 来源的特性。